Security key
74065P101
Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share (PRLD)
CUSIP: 74065P101
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 65,427,364
- Total 13F shares
- 30,289,302
- Share change
- -1,864,350
- Total reported value
- $23,267,043
- Price per share
- $0.77
- Number of holders
- 56
- Value change
- -$2,260,767
- Number of buys
- 20
- Number of sells
- 30
Report period
Q1 2025
Institutions
56
Top holders
10
PRLD full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Prelude Therapeutics Inc SEC filings
Prelude Therapeutics Inc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74065P101
Recent filing periods:
Top shareholders of PRLD - Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
17%
|
10,909,256
|
$13,909,301 | — | 31 Dec 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
15%
|
10,123,824
|
$12,907,876 | — | 31 Dec 2024 | |
| Boxer Capital Management, LLC |
13F
|
Company |
2.6%
|
1,708,187
|
$2,177,938 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
1.6%
|
1,069,773
|
$1,363,961 | — | 31 Dec 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.6%
|
1,029,199
|
$1,308,000 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.5%
|
1,010,392
|
$1,288,250 | — | 31 Dec 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1%
|
666,574
|
$849,882 | — | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.97%
|
634,500
|
$808,988 | — | 31 Dec 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.76%
|
494,497
|
$630,484 | — | 31 Dec 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.74%
|
485,381
|
$617,000 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.71%
|
462,555
|
$589,758 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.61%
|
402,336
|
$513,046 | — | 31 Dec 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.6%
|
392,155
|
$498,038 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.56%
|
365,159
|
$465,578 | — | 31 Dec 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.46%
|
300,000
|
$382,500 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.45%
|
293,396
|
$374,080 | — | 31 Dec 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.35%
|
231,839
|
$295,595 | — | 31 Dec 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.25%
|
166,830
|
$212,700 | — | 31 Dec 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.25%
|
160,652
|
$204,831 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.23%
|
148,326
|
$189,116 | — | 31 Dec 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.19%
|
123,899
|
$158,591 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.18%
|
117,200
|
$149,430 | — | 31 Dec 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.17%
|
111,000
|
$141,525 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.13%
|
83,387
|
$106,319 | — | 31 Dec 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.11%
|
72,799
|
$92,819 | — | 31 Dec 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.11%
|
70,045
|
$89,307 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.1%
|
67,390
|
$85,922 | — | 31 Dec 2024 | |
| EXCHANGE TRADED CONCEPTS, LLC |
13F
|
Company |
0.1%
|
64,409
|
$82,121 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.09%
|
61,149
|
$77,965 | — | 31 Dec 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.06%
|
38,339
|
$48,882 | — | 31 Dec 2024 | |
| Cerity Partners LLC |
13F
|
Company |
0.05%
|
32,877
|
$68,054 | — | 31 Dec 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.05%
|
29,773
|
$37,961 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
28,613
|
$36,482 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
20,654
|
$26,333 | — | 31 Dec 2024 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.03%
|
20,640
|
$25,594 | — | 31 Dec 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.03%
|
20,572
|
$26,229 | — | 31 Dec 2024 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.03%
|
18,814
|
$23,000 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.03%
|
16,797
|
$21,416 | — | 31 Dec 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.02%
|
12,493
|
$15,928 | — | 31 Dec 2024 | |
| Vanguard Personalized Indexing Management, LLC |
13F
|
Company |
0.02%
|
11,925
|
$15,204 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.02%
|
10,981
|
$13,912 | — | 31 Dec 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
10,376
|
$13,229 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
10,297
|
$13,129 | — | 31 Dec 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.02%
|
10,215
|
$13,024 | — | 31 Dec 2024 | |
| FMR LLC |
13F
|
Company |
0.01%
|
8,502
|
$10,840 | — | 31 Dec 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
7,737
|
$9,865 | — | 31 Dec 2024 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.01%
|
7,575
|
$9,658 | — | 31 Dec 2024 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.01%
|
6,554
|
$8,356 | — | 31 Dec 2024 | |
| Militia Capital Partners, LP |
13F
|
Company |
0.01%
|
4,300
|
$5,483 | — | 31 Dec 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
3,622
|
$4,618 | — | 31 Dec 2024 |
Institutional Holders of Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share (PRLD) as of Q1 2025
As of 31 Mar 2025,
Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share (PRLD) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,289,302 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, Boxer Capital Management, LLC, BlackRock, Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and MORGAN STANLEY.
This page lists
57
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
60
Q1 2025 holders
56
Holder diff
-4
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.